Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen alpha-1(IV) chain (COL4A1) is a protein encoded by the COL4A1 gene that is a major component of type IV collagen, a key structural element of basement membranes throughout the body[1][3][6][8]. This protein combines with other collagen IV chains to form a covalently cross-linked, flexible network critical for mechanically supporting tissues, shaping organs, filtering blood (notably in kidney glomeruli), and facilitating key biological processes such as cell adhesion, migration, differentiation, and survival[2][4][8]. COL4A1 is especially important for the integrity of vascular basement membranes. Mutations in COL4A1 are implicated in several hereditary diseases characterized by fragile blood vessels, such as COL4A1-related brain small-vessel disease, porencephaly, hereditary angiopathy with nephropathy, aneurysms, and muscle cramps, with involvement described in the brain, eyes, kidneys, muscles, and cardiovascular system[1][3]. COL4A1 is not currently considered a conventional therapeutic target like a receptor, enzyme, ion channel, or transporter, and there are no approved drugs that specifically and directly target this protein. However, its biomarker status is increasingly recognized for patient selection and risk stratification in genetic vascular disorders, particularly those involving small vessels and basement membrane integrity[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen alpha-1(IV) chain (COL4A1).